Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers
Bone Marrow Transplantation, Published online: 17 January 2020; doi:10.1038/s41409-020-0783-yBendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers
Source: Bone Marrow Transplantation - Category: Hematology Authors: Thomas Hueso Thomas Gastinne Sylvain Garciaz Emmanuelle Tchernonog Caroline Delette Ren é-Olivier Casasnovas Eric Durot Roch Houot Beno ît Tessoulin Olivier Tournilhac Sandra Malak Emmanuel Gyan Luc-Matthieu Fornecker Julie Abraham Baptiste Delapierre F Source Type: research
More News: Bone Marrow Transplant | Hematology | Lymphoma | Stem Cell Therapy | Stem Cells | Study | Transplants | Treanda